Authors: Gaillat, J Baranes, C Amsellem, D Cohen, A Bougon, N Riebbels, V Chauveau, E

Citation: J. Gaillat et al., Efficacy and safety of cefuroxime axetil compared to cefpodoxime proxetil in the treatment of acute exacerbations of chronic bronchitis., MED MAL INF, 31(2), 2001, pp. 52-60

Authors: Boulesteix, J Olivier, C Mselati, JC Guillot, M Chauveau, V Bougon, N Leblanc, F

Citation: J. Boulesteix et al., Lower respiratory tract infections in children: compared efficacy of cefuroxime axetil and cefpodoxime proxetil., MED MAL INF, 30(9), 2000, pp. 581-587

Authors: Le Chevalier, T Berille, J Zalcberg, JR Millward, MJ Monnier, A Douillard, JY McKeage, MJ James, R Soulas, F Loret, C Bougon, N Bizzari, JP

Citation: T. Le Chevalier et al., Overview of docetaxel (Taxotere)/cisplatin combination in non-small cell lung cancer, SEMIN ONCOL, 26(3), 1999, pp. 13-18

Authors: Le Chevalier, T Monnier, A Douillard, JY Ruffie, P Sun, XS Belli, L Ibrahim, N Bougon, N Berille, J

Citation: T. Le Chevalier et al., Docetaxel (Taxotere((R))) plus cisplatin: an active and well-tolerated combination in patients with advanced non-small cell lung cancer, EUR J CANC, 34(13), 1998, pp. 2032-2036